Identification and characterization of a novel scFv recognizing human and mouse CD133

Drug Delivery and Translational Research

Volumn 3, Issue 2, 2013, Pages 143-151

  Swaminathan, Suresh Kumar ^a   Niu, Lin ^a   Waldron, Nate ^b   Kalscheuer, Steve ^a   Zellmer, David M ^c   Olin, Michael R ^c   Ohlfest, John R ^c   Vallera, Daniel A ^b   Panyam, Jayanth ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Cancer stem cells; CD133; Prominin 1; ScFv

Indexed keywords

CD133 ANTIGEN; FLUORESCEIN ISOTHIOCYANATE; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

ANIMAL CELL; ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; CROSS REACTION; GENETIC TRANSFECTION; GLYCOSYLATION; HUMAN; HYBRIDOMA CELL CULTURE; IMMUNOHISTOCHEMISTRY; MOLECULAR CLONING; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL;

EID: 84874810590     PISSN: 2190393X     EISSN: 21903948     Source Type: Journal    
DOI: 10.1007/s13346-012-0099-6     Document Type: Article

References (25)

1. Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG, et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood. 1997; 90(12): 5002-12.
2. Uchida N, Buck DW, He D, Reitsma MJ, Masek M, Phan TV, et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A. 2000; 97(26): 14720-5. doi: 10. 1073/pnas. 97. 26. 1472097/26/14720.
3. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood. 2000; 95(3): 952-8.
4. Weigmann A, Corbeil D, Hellwig A, Huttner WB. Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells. Proc Natl Acad Sci U S A. 1997; 94(23): 12425-30.
5. Fabrizi E, Di Martino S, Pelacchi F, Ricci-Vitiani L. Therapeutic implications of colon cancer stem cells. World J Gastroenterol. 2010; 16(31): 3871-7.
6. Harper LJ, Piper K, Common J, Fortune F, Mackenzie IC. Stem cell patterns in cell lines derived from head and neck squamous cell carcinoma. J Oral Pathol Med. 2007; 36(10): 594-603. doi: 10. 1111/j. 1600-0714. 2007. 00617. x.
7. Du Z, Qin R, Wei C, Wang M, Shi C, Tian R, et al. Pancreatic cancer cells resistant to chemoradiotherapy rich in "stem-cell-like" tumor cells. Dig Dis Sci. 2010; 56(3): 741-50. doi: 10. 1007/s10620-010-1340-0.
8. + breast carcinoma cells. Drug Deliv and Transl Res. 2012. doi: 10. 1007/s13346-012-0066-2.
9. Waldron NN, Kaufman DS, Oh S, Inde Z, Hexum MK, Ohlfest JR, et al. Targeting tumor-initiating cancer cells with dCD133KDEL shows impressive tumor reductions in a xenotransplant model of human head and neck cancer. Mol Cancer Ther. 2011; 10(10): 1829-38. doi: 10. 1158/1535-7163. MCT-11-0206.
10. Bidlingmaier S, Zhu X, Liu B. The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells. J Mol Med. 2008; 86(9): 1025-32. doi: 10. 1007/s00109-008-0357-8.
11. Kemper K, Sprick MR, de Bree M, Scopelliti A, Vermeulen L, Hoek M, et al. The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation. Cancer Res. 2010; 70(2): 719-29. doi: 10. 1158/0008-5472. CAN-09-1820.
12. Florek M, Haase M, Marzesco AM, Freund D, Ehninger G, Huttner WB, et al. Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer. Cell Tissue Res. 2005; 319(1): 15-26. doi: 10. 1007/s00441-004-1018-z.
13. Swaminathan SK, Olin MR, Forster CL, Cruz KSS, Panyam J, Ohlfest JR. Identification of a novel monoclonal antibody recognizing CD133. J Immunol Methods. 2010; 361(1-2): 110-5.
14. Wiesner SM, Decker SA, Larson JD, Ericson K, Forster C, Gallardo JL, et al. De novo induction of genetically engineered brain tumors in mice using plasmid DNA. Cancer Res. 2009; 69(2): 431-9. doi: 10. 1158/0008-5472. CAN-08-1800.
15. Swaminathan SK, Olin MR, Forster CL, Cruz KS, Panyam J, Ohlfest JR. Identification of a novel monoclonal antibody recognizing CD133. J Immunol Methods. 2010; 361(1-2): 110-5. doi: 10. 1016/j. jim. 2010. 07. 007.
16. Vander Griend DJ, Karthaus WL, Dalrymple S, Meeker A, DeMarzo AM, Isaacs JT. The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells. Cancer Res. 2008; 68(23): 9703-11. doi: 10. 1158/0008-5472. CAN-08-3084.
17. Jaksch M, Munera J, Bajpai R, Terskikh A, Oshima RG. Cell cycle-dependent variation of a CD133 epitope in human embryonic stem cell, colon cancer, and melanoma cell lines. Cancer Res. 2008; 68(19): 7882-6. doi: 10. 1158/0008-5472. CAN-08-0723.
18. Quirici N, Soligo D, Caneva L, Servida F, Bossolasco P, Deliliers GL. Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells. Br J Haematol. 2001; 115(1): 186-94.
19. Sugiyama T, Rodriguez RT, McLean GW, Kim SK. Conserved markers of fetal pancreatic epithelium permit prospective isolation of islet progenitor cells by FACS. Proc Natl Acad Sci U S A. 2007; 104(1): 175-80. doi: 10. 1073/pnas. 0609490104.
20. Shmelkov SV, St Clair R, Lyden D, Rafii S. AC133/CD133/Prominin-1. Int J Biochem Cell Biol. 2005; 37(4): 715-9. doi: 10. 1016/j. biocel. 2004. 08. 010.
21. Shmelkov SV, Jun L, St Clair R, McGarrigle D, Derderian CA, Usenko JK, et al. Alternative promoters regulate transcription of the gene that encodes stem cell surface protein AC133. Blood. 2004; 103(6): 2055-61.
22. Pellacani D, Packer RJ, Frame FM, Oldridge EE, Berry PA, Labarthe M-C et al. Regulation of the stem cell marker CD133 is independent of promoter hypermethylation in human epithelial differentiation and cancer. Mol Cancer. 2011; 10: 94.
23. Roper K, Corbeil D, Huttner WB. Retention of prominin in microvilli reveals distinct cholesterol-based lipid micro-domains in the apical plasma membrane. Nat Cell Biol. 2000; 2(9): 582-92.
24. Miraglia S, Godfrey W, Yin AH, Atkins K, Warnke R, Holden JT, et al. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood. 1997; 90(12): 5013-21.
25. Mak AB, Blakely KM, Williams RA, Penttila P-A, Shukalyuk AI, Osman KT, et al. CD133 protein N-glycosylation processing contributes to cell surface recognition of the primitive cell marker AC133 epitope. J Biol Chem. 2011; 286(47): 41046-56.